SCHOENBERG MARK (Chief Medical Officer) sold 7.2% of their position (10K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $350.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0001437749-26-021523
Officer· Chief Medical Officer
Since Jan 2019
-10K
Net shares
Net seller
$350.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−10K
Price / share
$35.01
Trade value
$350.10K
% of position
7.2%
6/22/2026
139.76K→129.76K
Total
Net shares
−10K
Net value
-$350.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/22/2026 | S · Sale | −10K | $35.01 | $350.10K | 7.2% | 139.76K | 129.76K |
| Total | −10K | -$350.10K | ||||||
Derivative Transactions0
No derivative transactions reported